Diagnosing ABL: Understanding Your Lab Results
At a Glance
Abetalipoproteinemia is suspected when LDL cholesterol and apoB are extremely low, often below 15 mg/dL, with possible vitamin deficiencies or acanthocytes on a blood smear. Testing for two MTTP mutations can support confirmation, while other causes of very low cholesterol must be excluded.
Diagnosing abetalipoproteinemia (ABL) requires a combination of specialized blood tests and genetic analysis. Because ABL is so rare, your doctor will look for a very specific pattern in your lab results—one that shows your body is unable to effectively produce the “transport ships” (lipoproteins) needed to move fats and vitamins [1][2]. Your doctor will also rule out secondary causes of very low cholesterol, such as malnutrition, hyperthyroidism, or advanced liver disease.
The Core Lipid Markers: LDL and apoB
The most striking feature of ABL is extremely low levels of cholesterol and certain proteins in the blood. Two markers are especially important clinical clues:
- LDL-C (Low-Density Lipoprotein Cholesterol): Often called “bad cholesterol,” this is usually very low or even undetectable in ABL. Diagnostic guidelines often look for levels below 15 mg/dL [1][2].
- Apolipoprotein B (apoB): This is the structural protein needed to build fat-transporting containers. In ABL, apoB levels are typically below 15 mg/dL or completely absent [1][2].
While these numbers (below 15 mg/dL) are highly suggestive in the right clinical context, they are not absolute diagnostic cutoffs and can vary with age and laboratory methods [3].
Examining Your Blood Under a Microscope
One of the unique signs of ABL is found by looking at your blood cells under a microscope, a test called a peripheral blood smear.
In some cases (reported around 58% in a review), patients have acanthocytosis [4]. This means your red blood cells look “spiky” or “thorny” instead of smooth and round [5][6]. These spikes occur because the lack of fats in your blood changes the structure of the red blood cell’s outer “skin” (membrane) [6]. While it is a variable morphological clue rather than a strict requirement—and it does not inevitably cause anemia—finding them is a major clue for your medical team [4].
The Role of Genetic Testing
Genetic testing can help confirm a diagnosis of ABL. Your doctor will look for mutations in the MTTP gene [7].
To have ABL, you must have two mutations—one from each parent. This is called a biallelic mutation [1]. You might have the same mutation from both parents (homozygous) or two different mutations in the same gene (compound heterozygous) [7][8]. Confirming an MTTP mutation helps distinguish ABL from other conditions, like HoFHBL (caused by the APOB gene). However, a negative genetic panel doesn’t always definitively rule out ABL (as some complex variants can be missed), and a “variant of uncertain significance” requires careful interpretation by a genetic counselor [9][10].
Your Completeness Checklist
When reviewing your lab reports, ensure you and your doctor have discussed each of these key areas:
| Test Category | Specific Lab | Why it Matters in ABL |
|---|---|---|
| Lipid Profile | LDL-C, Total Cholesterol, Triglycerides | To identify the severe drop in blood fats typical of ABL [1]. |
| Protein Markers | Apolipoprotein B (apoB) | To confirm the body lacks the primary building block for fat transport [2]. |
| Vitamin Levels | Vitamins A, D, E, and K | To measure deficiencies and guide your doses. Vitamin E results may need interpretation relative to total lipids [11][12]. |
| Blood Structure | Peripheral Blood Smear | To check for “spiky” red blood cells (acanthocytosis) [4]. |
| Clotting Ability | PT / INR (Prothrombin Time) | A functional test of clotting time. A prolonged time may reflect Vitamin K status, but liver disease and other factors can also affect it [11]. |
| Liver Health | ALT / AST (Transaminases) | To monitor for liver stress or fat accumulation in the liver [4][12]. |
| Genetic Test | MTTP Gene Analysis | To help provide a definitive diagnosis and distinguish ABL from other conditions [7]. |
If any of these tests are missing from your records, it is worth asking your care team if they should be ordered to complete your clinical picture. Monitoring these labs regularly is a standard part of staying healthy with ABL [1].
Common questions in this guide
Can very low LDL and apoB levels alone diagnose abetalipoproteinemia?
What are acanthocytes, and do they prove ABL?
What does MTTP genetic testing show in abetalipoproteinemia?
Which laboratory tests are typically part of an ABL evaluation?
What can a high PT or INR mean in abetalipoproteinemia?
Get notified when new evidence is published on Abetalipoproteinemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
Current Diagnosis and Management of Abetalipoproteinemia.
Takahashi M, Okazaki H, Ohashi K, et al.
Journal of atherosclerosis and thrombosis 2021; (28(10)):1009-1019 doi:10.5551/jat.RV17056.
PMID: 33994405 - 2
A novel mutation, Ile344Asn, in microsomal triglyceride transfer protein abolishes binding to protein disulfide isomerase.
Valmiki S, Bredefeld C, Hussain MM
Journal of lipid research 2025; (66(1)):100725 doi:10.1016/j.jlr.2024.100725.
PMID: 39672332 - 3
Generation of hepatoma cell lines deficient in microsomal triglyceride transfer protein.
Anaganti N, Chattopadhyay A, Poirier JT, Hussain MM
Journal of lipid research 2022; (63(9)):100257 doi:10.1016/j.jlr.2022.100257.
PMID: 35931202 - 4
A novel p.Gly417Valfs*12 mutation in the MTTP gene causing abetalipoproteinemia: Presentation of the first patient in Mexico and analysis of the previously reported cases.
Rodríguez Gutiérrez PG, González García JR, Castillo De León YA, et al.
Journal of clinical laboratory analysis 2021; (35(3)):e23672 doi:10.1002/jcla.23672.
PMID: 33258201 - 5
Impaired Cytoskeletal and Membrane Biophysical Properties of Acanthocytes in Hypobetalipoproteinemia - A Case Study.
Cloos AS, Daenen LGM, Maja M, et al.
Frontiers in physiology 2021; (12()):638027 doi:10.3389/fphys.2021.638027.
PMID: 33708142 - 6
Forty year follow-up of three patients with complete absence of apolipoprotein B-containing lipoproteins.
Le R, Zhao L, Hegele RA
Journal of clinical lipidology 2022; (16(2)):155-159 doi:10.1016/j.jacl.2022.02.003.
PMID: 35221233 - 7
High carrier frequency for abetalipoproteinemia and evidence of a founder variant in a French-Canadian population.
Guay SP, Paquette M, Girard L, et al.
Journal of clinical lipidology 2024; (18(4)):e625-e630 doi:10.1016/j.jacl.2024.04.132.
PMID: 38908974 - 8
Normal serum ApoB48 and red cells vitamin E concentrations after supplementation in a novel compound heterozygous case of abetalipoproteinemia.
Di Filippo M, Collardeau Frachon S, Janin A, et al.
Atherosclerosis 2019; (284()):75-82 doi:10.1016/j.atherosclerosis.2019.02.016.
PMID: 30875496 - 9
Current Diagnosis and Management of Familial Hypobetalipoproteinemia 1.
Wakabayashi T, Takahashi M, Okazaki H, et al.
Journal of atherosclerosis and thrombosis 2024; (31(7)):1005-1023 doi:10.5551/jat.RV22018.
PMID: 38710625 - 10
Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B.
Yilmaz BS, Mungan NO, Di Leo E, et al.
Clinica chimica acta; international journal of clinical chemistry 2016; (452()):185-90.
PMID: 26612772 - 11
An Unusual Presentation of Hemorrhagic Disease in an Infant: A Probable Case of Abetalipoproteinemia.
Sivamurukan P, Boddu D, Pulimood A, Agarwal I
Journal of pediatric hematology/oncology 2021; (43(3)):e429-e430 doi:10.1097/MPH.0000000000001831.
PMID: 32433446 - 12
A New Case of Abetalipoproteinemia Caused by Novel Compound Heterozygote Mutations in the MTTP Gene without Fat or Vitamin Malabsorption.
Sasaki K, Tada H, Komatsu T, et al.
Journal of atherosclerosis and thrombosis 2024; (31(11)):1634-1640 doi:10.5551/jat.64730.
PMID: 38749717
This page explains laboratory and genetic testing used to evaluate abetalipoproteinemia for informational purposes only and does not constitute medical advice. Your doctor and genetic counselor should interpret your results in the context of your overall health.